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ABSTRACT 
Introduction 
This service evaluation explored and reported findings from a new physiotherapist-led service offering 
suprascapular nerve blocks (SSNBs) to patients with persistent shoulder pain. 
Methods 
We collected data before the SSNB injection and at 6 weeks and 6 months follow-up from 
consecutive patients with persistent shoulder pain being treated by physiotherapists or an 
anaesthetist.  Outcomes were patient-reported pain (numerical rating scale (NRS 0 to 10)), patient 
specific functional score (PSFS), and health-related quality of life (EQ5D-5L). Exploratory analyses 
compared baseline and follow-up scores within each clinician delivery group (Physiotherapists, 
anaesthetist).  
 
Results 
40 patients (mean age 57 (SD 12); female 63%) received a SSNB from a physiotherapist, 8 patients 
(mean age 59 (SD 11); female 88%) received a SSNB by an anaesthetist. At 6 weeks follow-up, the 
physiotherapy group showed a mean reduction in pain: 2.2 (95% CI 1.3 to 3.0) and improvement in 
function: -1.3 (95% CI -1.9 to -0.4). Similar changes were found in those treated by the anaesthetist 
(pain 1.3, (95% CI -1.18 to 3.80); function -1.4 (95% CI -3.18 to 0.35). Very small changes, that were 
not statistically significant, were found in quality of life (EQ5D-5L) scores. At 6 months follow-up, the 
mean reduction in pain (NRS) was maintained at 2.0 (95% CI 0.99 to 2.95) for the physiotherapy 
group. 
Conclusion 
The results provide early, exploratory evidence that patients with persistent shoulder pain treated by 
physiotherapists using palpation-guided SSNBs achieve clinically important changes in pain and 
function in the short and medium term.  
  
INTRODUCTION 
Persistent shoulder pain accounts for 15% of all musculoskeletal conditions and is associated with 
high patient burden and health care costs (Meislin et al., 2008; Borstand & Woeste, 2015).  Among 
patients seeking treatment for their shoulder pain, approximately half have ongoing symptoms 12 
months from first consulting a health professional (van der Windt et al., 1996; Chester et al., 2013; 
Laslett et al., 2015). When persistent, shoulder pain is often thought to be multifactorial involving 
pathology affecting more than one anatomical structure in the shoulder, potentially requiring more 
complex management (Meislin et al. 2005). It is therefore important to identify effective clinical 
interventions that can address multiple factors simultaneously for patients with persistent 
musculoskeletal shoulder pain. 
There is a moderate level of evidence from two systematic reviews to support the short-term 
effectiveness (for 12 weeks or less) of suprascapular nerve block (SSNBs) injections for persistent 
shoulder pain compared to placebo (Favejee et al.,2011; Chang et al., 2016) and physiotherapist-led 
exercise (Chang et al., 2016). The usefulness of physiotherapist (PT)-led exercise in a chronically 
sensitised pain state requires careful consideration. Peripheral input to the central nervous system 
resulting from stretching or strengthening exercises, whilst useful in the long-term management, can 
stimulate peripheral nociceptors and further aggravate the nociceptive barrage and potentially worsen 
pain (Borstad & Woeste, 2015). Using SSNBs prior to providing a course of exercise could temporally 
break the afferent nociceptive input and create an opportunity to proceed with more effective exercise 
rehabilitation in the short, medium and long term (Bialosky et al., 2009). There is limited evidence to 
date that supports the addition of exercise after SSNB (Di Lorenzo et al., 2006; Klç et al. 2015).     
SSNBs can be delivered using ultrasound, fluoroscopy and palpation-guided delivery techniques. It 
has been suggested that ultrasound and fluoroscopy techniques are less likely to result in serious 
complications such as pneumothorax and inadvertent neurovascular injury (Gorthi et al. 2010).  
However, evidence exists to support the landmark-guided palpation method as a safe method of 
delivering SSNBs (Shanahan et al., 2003; Shanahan et al., 2004).  
Service Model 
At one National Health Service (NHS) hospital Trust in the West Midlands in England, patients with 
persistent shoulder pain had historically been referred to an anaesthetist for a therapeutic SSNB 
performed under ultrasound guidance. Waiting times for the procedure usually exceeded more than 
one month, impacting negatively on the national 18 week referral to treatment target.  This target was 
set by the NHS Constitution to ensure that patients (with non-urgent problems) should wait no longer 
than 18 weeks from general practitioner referral to treatment in secondary care (NHS England, 2013). 
Patients receiving SSNBs did not receive a physiotherapy referral following their nerve block, but 
would be followed up in a clinic by an orthopaedic surgeon to evaluate short-term outcomes and 
decide on further onward management if necessary e.g. referral to a pain clinic.   
It was decided to re-develop the service to explore alternative ways to deliver SSNBs to improve 
access to SSNB procedures for patients with persistent shoulder pain and improve follow-up care.  
Advanced practitioner PTs based in secondary care, who had a specialist interest in shoulder pain 
management, were trained to perform palpation-guided SSNBs. All PTs were already trained and 
competent in injection therapy for the shoulder.  Additional training in SSNBs was provided on a one 
to one basis in terms of a theoretical component of dose and risks as well as an observational 
component on technique by either a consultant anaesthetist or consultant physiotherapist.  A variable 
amount of observational training was required depending on the individual physiotherapist, and 
ranged between one and five observed SSNBs. In addition to receiving a SSNB, patients were also 
prescribed home exercises from a PT.  Patients received a six week follow-up appointment with a 
specialist PT, rather than the orthopaedic consultant. In addition, patients received a six month 
telephone follow-up by a physiotherapy assistant to establish medium-term clinical outcomes. This 
exploratory service evaluation collected patient reported outcome data from patients who received 
PT-led SSNBs in combination with exercise and provided an initial comparison with outcomes from 
patients who had received their SSNBs using ultrasound guidance from a medical doctor (in this case 
an anaesthetist) in combination with exercise for patients with persistent shoulder pain.  
METHODS 
This prospective service evaluation was conducted in the physiotherapy department of an NHS 
hospital Trust in the West Midlands, England. The aim was to recruit up to 50 patients within one year 
as this has been the recommended number of patients to be involved in a service evaluation of this 
kind (CACG, 2008).  It was anticipated some of the patients would have a SSNB using an ultrasound-
guided technique by an anaesthetist to enable an exploration of the outcomes achieved for each of 
the two approaches.   Outcome measures were collected at baseline (prior to receiving a SSNB), at 
six weeks (short-term outcomes) and at six months (medium-term outcome) following the SSNB.  
Patients provided written consent to be contacted by telephone review at six months as this was an 
additional requirement to their usual care. The service evaluation was approved and registered by the 
clinical effectiveness and audit team at the participating hospital Trust (ID 2865) prior to 
commencement.  In the UK service evaluations do not require research ethical approval (NHS HRA, 
2007), however ethical principles were considered (as recommended by Healthcare Quality 
Improvement Partnership) (Brain et al., 2011)) to ensure the service evaluation adhered to the 
recommended clinical governance standards.  
 
Participant population and data collection process 
Patients were referred to physiotherapy from orthopaedic consultants, general practitioners, or PTs 
working in a primary care setting.  All patients were aged 18 years and over and presented with 
persistent musculoskeletal shoulder pain defined as pain lasting greater than three months and 
having failed to respond to previous interventions.  Patients were assessed by an advanced 
practitioner PT to determine suitability, prior to being offered a SSNB, which was provided one week 
later (as per standard practice).   
Baseline data were collected in the PT clinic by the PTs immediately prior to the patient receiving the 
SSNB, regardless of whether the SSNB was provided by the anaesthetist or the PT.  Baseline data 
included demographic data (age, gender and occupation), clinical characteristics (clinical diagnosis, 
previous treatment and pain duration, dominant arm and shoulder involved), and patient reported 
outcome measures (pain measured using the numerical rating scale (NRS) (Hawker, 2011), function 
measured using the patient specific functional score (PSFS) (Hefford et al., 2012; Koehorst et al., 
2014), and health related quality of life (measured using the EQ5D-5L) (König et al., 2009)). All three 
patient reported outcome measures are routinely collected in this NHS service.  For all patients, 
outcomes at six weeks were collected at the clinical follow-up appointment with a PT.  Follow-up data 
about pain intensity (NRS) at six months were collected at a telephone review by a physiotherapy 
assistant.  Patient data were stored in a secure location in the physiotherpay department and aligned 
with hospital policy regarding confidentiality and anonymity.  
 
SSNB delivery 
Participants received a single SSNB either by a PT using a palpation-guided technique (Meier 
technique as described by Fernandes et al. (2012a)) (see Figure 1), or by a consultant anaesthetist 
using an ultrasound-guided technique. At the time of making the appointment for the SSNB, it was not 
known whether the patients would receive SSNBs by the anaesthetist or a PT. The decision on who 
would provide the SSNB was based on clinician availability on the day.  During the course of the 
service evaluation, a number of clinics had been arranged for the anaesthetist to be involved in 
providing ultrasound-guided SSNBs.   Due to unforeseen personal and work commitments, the 
anaesthetist was only available to attend few of the planned sessions leading to a disproportionate 
number of patients seen by the advanced practitioner PTs. Within the injectate, all patients received a 
corticosteroid (40mg (1ml) methylprednisolone acetate) and an anaesthetic (either 100mg (10ml) 
Lidocaine hydrochloride or 50mg (10ml) Levobupivacaine).  An anaesthetic volume of 10ml has been 
advocated for use in SSNBs (Fernandes et al. 2012b).  Variability in anaesthetic medications meant 
that patients who had contraindications for one medication were able to receive a SSNB using the 
alternative medication. All SSNBs (including those delivered by the anaesthetist) were delivered in the 
PT department.  All patients (including those who had received their SSNBs from the anaesthetist) 
were advised relative rest for a period of two days following the procedure and were provided with 
prescribed, individualised home exercises by a PT. The provision of home exercises was not 
standardised. If any of the patients struggled to understand the exercises prior to the SSNB, a further 
PT appointment was arranged for after the SSNB.  Additional PT appointments were not necessarily 
with advanced practitioners but were provided by one of the other physiotherapists working in the 
shoulder pain service at the time.   
 Outcome measures 
Pain intensity (Numerical Rating Scale) 
Patients were asked to mark the ‘worst’ shoulder pain they had experienced in the preceding week on 
a Numerical Rating Scale (NRS 0-10; where 0 represented ‘no pain at all’ and 10 represented ‘worse 
pain imaginable’). The 0-10 NRS for pain is a validated and frequently used measure to assess 
changes in shoulder pain in response to interventions (Hawker, 2011).  A change of two points on a 0-
10 point scale has been identified to represent a clinically meaningful change in shoulder pain 
(Michener, 2011).  Change scores were calculated by subtracting the follow-up pain scores from the 
baseline pain scores. Therefore, 0 represented no change; positive values indicated an improvement 
and negative values represented worsening of pain. As SSNBs are primarily thought to have an effect 
on pain, the NRS was considered the primary outcome in this evaluation. 
Function (Patient Specific Functional Score) 
The Patient Specific Functional Score (PSFS) is an outcome used to identify changes in physical 
function (Hefford et al., 2012; Koehorst et al., 2014). Patients were asked to identify up to three 
physical functions currently limited by their shoulder pain and rate each on the scale of 0 to 10, where 
0 represents ‘no function’ to 10 which represents ‘best function’.  The score was taken as the mean 
score for the three functions. Change scores were calculated by subtracting the follow-up PSFS from 
the baseline PSFS.  Therefore, 0 represented no change; negative values indicated an improvement 
and positive values represented worsening of function. Meaningful changes in function have been 
reported to be 1.2 points for upper extremity problems in general (Hefford et al., 2012), and 1.3 points 
for shoulder pain specifically (Koehorst et al. 2014). In this service evaluation a change of -1.3 points 
or more on the scale represented a meaningful improvement. 
Health-related quality of life (EQ5D-5L) 
The EQ5D-5L (EuroQol Group, 2009) is a generic outcome measure, validated to identify changes in 
health-related quality of life (König et al., 2009).  It has been reported to have a good correlation with 
shoulder-specific questionnaires (Paul et al., 2004).  The scale asks five questions relating to physical 
and psychological domains, as well as asking the patient to score their health on a 0-100 health state 
thermometer.  An online electronic formula calculates scores (available at 
http://www.euroqol.org/about-eq-5d/valuation-of-eq-5d/eq-5d-5l-value-sets.html).   The scores range 
from -0.11 (poor health) to 1 (full health) (Kind et al., 1998; Revicki et al., 2009).   A clinically 
meaningful change in EQ5D-5L score has been identified as 0.10 for patients with chronic 
musculoskeletal pain conditions (Yoshizawa et al. 2016).  
 
Data Analyses 
All analyses were performed using Statistical Package for the Social Sciences (SPSS), version 24 
(http://share.uoa.gr/public/Software/SPSS/SPSS24/Manuals/IBM%20SPSS%20Statistics%20Base.pd
f) .  Baseline continuous variables (age, pain, function and health-related quality of life) were reported 
as mean and standard deviation. Baseline categorical data (e.g. occupation and diagnosis) were 
reported as numbers and percentages.   As this was an exploratory evaluation with a small sample of 
patients, and no means to balance the numbers in each group, we did not attempt to statistically 
compare the results of patients treated by PTs and medical doctors, but instead provide a descriptive 
analysis of changes in pain, function and quality of life over time. Paired samples t-tests were used for 
parametric data to test statistical significance of changes in scores from baseline to follow-up within 
each patient group. Success of the PT-led service was determined by mean pain scores reaching a 
meaningful improvement (at least 2 points on the 0-10 NRS) and statistically significant reduction in 
pain, compared to baseline, at 6 weeks and 6 months.  
RESULTS 
A consecutive sample of 48 patients received SSNBs between July 2015 and July 2016 and were 
included in the service evaluation.  All patients received their SSNB within one month from when the 
clinical decision to proceed with a SSNB was made.  Of these, 40 received palpation-guided SSNBs 
from one of three PTs and eight received ultrasound-guided SSNBs from an anaesthetist.  
Baseline results (table 1) indicated that both groups had similar characteristics for most variables. 
Patients in both groups generally had high pain scores (mean NRS=7.8) and low functional scores 
(mean PSFS=3.4) at baseline.  All had received previous interventions, the majority of which were 
conservative treatments in the form of different treatment modalities used in physiotherapy and 
previous injections around the shoulder (intra-articular and/or soft-tissue).  No patients had previously 
received SSNBs.  The majority of patients in both groups were assessed clinically and diagnosed with 
multiple components contributing to their shoulder pain, for example rotator cuff disorder with 
acromio-clavicular joint osteoarthritis.  Follow-up rates at six weeks were good, with data available for 
45 patients (93%) for pain intensity (NRS), 42 patients (88%) for function (PSFS) and 43 patients 
(90%) for quality of life (EQ5D-5L).  Follow-up rates remained good at six months, with pain intensity 
data available for 42 patients (88%).  There were no reports of harm associated with the procedure, 
and none of the patients required anything other than standard after-care (30 minutes rest in the 
department following the SSNB).  One patient (in the PT-led SSNB group) reported to have felt 
lightheaded following the procedure which resolved a few hours following the SSNB. 
 
Outcomes 
Table 2 presents the results for at baseline, 6 weeks and, (for pain (NRS) measures) at 6 months 
follow-up, for both patient groups.   
Pain intensity (Numerical Rating Scale) 
Mean pain intensity decreased from 7.7 at baseline to 5.5 at 6 weeks follow-up and 5.7 at 6 months 
follow-up in the PT group. Mean improvement from baseline was clinically meaningful and statistically 
significant at 6 weeks (mean change 2.2; 95% CI 1.3 to 3.0), and at 6 months (mean change 2.0; 95% 
CI 0.99 to 2.95).  In the anaesthetist group, mean pain intensity decreased from 7.8 to 6.5 at 6 weeks 
and 5.3 at 6 months follow-up. Mean improvements in the anaesthetist group were not statistically 
significant at either time point, but did reach the pre-defined threshold for a clinically meaningful 
improvement at six months (see Table 2; Figure 2).   
 
Function (Patient Specific Functional Score) 
Mean function increased from 3.6 at baseline to 4.9 at 6 week follow-up in the PT group.  Mean 
improvement was clinically meaningful and statistically significant at 6 weeks (mean change -1.3; 95% 
CI -1.9 to -0.4).  In the anaesthetist group, mean function increased from 2.9 at baseline to 4.6 at 6 
weeks. These changes were also clinically meaningful, but not statistically significant at 6 weeks (-
1.41; -3.18 to 0.35).  
 
Health-related quality of life (EQ5D-5L) 
Health-related quality of life increased from 0.46 at baseline to 0.50 at 6 week follow-up in the PT 
group, and from 0.38 to 0.46 at 6 weeks in the anaesthetist group.  The changes from baseline in 
neither group met the cut-point for meaningful change or were statistically significant (p=>0.05).  
. 
  
DISCUSSION 
Patients with persistent shoulder pain receiving SSNBs delivered by advanced practitioner PTs using 
a palpation-guided technique with accompanying prescribed exercise reported clinically meaningful 
reductions in pain and function in the short term.  Improvements in pain were maintained in the 
medium term.  The improvements observed were similar to those achieved by ultrasound-guided 
SSNBs given by an anaesthetist.  Findings from this service evaluation have resulted in a change to 
service delivery at the NHS hospital Trust in which the service evaluation was conducted.  All patients 
attending the orthopaedic services who require a therapeutic SSNB are now referred to a PT rather 
than to an anaesthetist.    
The mean change in pain at 6 weeks after the SSNB for the PT-led group was 2.2 which represented 
a clinically meaningful difference. Studies evaluating landmark-guided SSNBs on mixed pathology 
chronic shoulder patients have reported mean reductions in pain less that this: 1.2 at 4 weeks follow-
up (Shanahan et al. 2004), 0.6 at one month follow-up (Taskaynatan et al., 2005), and 1.3 and 0.5 at 
12 weeks follow-up (Shanahan et al., 2003; Shanahan et al. 2004).  Unlike those previous studies, in 
this service evaluation SSNBs were provided by PTs in conjunction with prescribed, individualised 
exercise.  
Previous studies have evaluated the benefit of SSNBs with physiotherapist-led exercises but it is not 
clear whether physiotherapists also provided the SSNBs (Dahan et al., 2000; DiLorenzo et al., 2006; 
Klç et al. 2015). To the authors’ knowledge, this is the first formal evaluation of shoulder pain patients’ 
outcomes from PTs providing SSNBs with exercise.  
In respect of the injection technique, findings from this service evaluation are consistent with other 
reports that palpation-guided SSNBs are as safe as ultrasound-guided procedures (Jones & 
Chattopadhyay, 1999; Shanahan et al., 2003; Taskaynatan et al., 2006; DiLorenzo et al., 2006). This 
has implications for overall cost in terms of the ultrasound equipment, additional training 
requirements, and additional time to deliver a SSNB under ultrasound guidance.  PTs providing the 
SSNBs instead of medical doctors could also lead to further cost reductions.  The cost of a consultant 
anaesthetist providing ultrasound-guided injections compared to an advanced practice PT providing 
landmark-guided SSNBs (as was the case in this service evaluation) is nearly four times more 
expensive (unit costs of a landmark guided injection by a PT £39.00 versus ultrasound-guided 
anaesthetist injection  £149.00) (PSSRC, 2015).  Delivering SSNBs using a palpation-guided method 
by PTs could potentially be an effective means of reducing health care costs in the management of 
patients with persistent shoulder pain.    
The findings from this service evaluation could have implications for services in other UK healthcare 
settings.  Patients with persistent pain who might benefit from SSNBs typically tend to receive their 
nerve blocks in secondary or tertiary-care settings (such as pain management clinics) by medical 
doctors often as a stand-alone treatment (Fernandes, 2012b).  In the UK, patients often need to wait 
long periods to receive their treatment due to increasing pressures on these services.  In the authors’ 
opinion, rarely will a patient receive prescribed exercises at the same time as the delivery of a SSNB 
by a medical doctor. In some cases they will need to wait to be referred to see a PT following their 
SSNB, in other cases they will not receive any physiotherapy at all.  If more PTs could provide 
SSNBs, patients could benefit from reduced waiting times to receive their SSNB as well as the 
benefits from prescribed exercises.   
A large number of patients with musculoskeletal shoulder pain develop persistent shoulder pain.   The 
patients taking part in this service evaluation had a mean duration of pain of 58 months (4.8 years).  
All had received other interventions, with poor outcomes, prior to receiving their SSNB. The mean 
pain reduction following SSNB with exercise presented here indicates that this intervention might be 
beneficial earlier in the care pathway.  Future research should seek to identify which patients are at 
high risk of a poor outcome from common shoulder treatments, and which patients may potentially 
benefit from SSNBs. 
This service evaluation is not without limitations.  It is recognised that only limited information can be 
gained from evaluating the comparative group of patients who received SSNBs by the consultant 
anaesthetist under ultrasound guidance as numbers in this group were small and the design of the 
study was not a randomised trial. Any additional PT intervention received by patients in either group 
was not standardised nor recorded in detail in terms of type, frequency or intensity of exercise. The 
EQ5D-5L was the tool used to evaluate health related quality of life.  Unlike the pain and functional 
outcomes, the EQ5D-5L did not show any statistically significant or clinically meaningful change.  This 
questions the responsiveness of EQ5D-5L as an outcome measure for patients with shoulder pain. 
The evaluation also has some strengths: it is the first to provide an exploratory evaluation of SSNBs 
delivered by PTs and presents outcomes up to 6 months after the intervention.  No published 
research studies evaluating SSNBs to date have followed up participants after SSNB beyond 12 
weeks.  In addition it has provided some early suggestion that SSNBs delivered by PTs might be as 
effective as those provided by medical doctors.  A recent study comparing efficacy of physiotherapists 
providing steroid injections (in this case to the sub-acromial region of the shoulder) compared to 
medical doctors reported equivocal outcomes (Marks et al., 2016).  Research that tests the 
effectiveness of adding SSNBs to physiotherapist-led exercise for persistent shoulder pain is needed. 
 
IMPLICATIONS 
This service evaluation provides exploratory evidence that SSNBs delivered by PTs using a palpation-
guided approach achieved reductions in pain and improvements in function for patients with persistent 
shoulder pain. Research that investigates the clinical and cost-effectiveness of this treatment provided 
by PTs is needed. It could have the potential for wider use in PT practice for patients with persistent 
shoulder pain who have failed to respond or are likely to have a poor outcome from other treatments. 
 
Key words 
 
Suprascapular nerve block; Physiotherapy.
Table 1: Baseline characteristics of patients at baseline (n=48) 
 
 Physiotherapist 
 (Palpation-guided) SSNB 
(n=40) 
 
Anaesthetist 
(Ultrasound-guided) SSNB 
(n=8) 
 
Mean (SD) Number 
analysed 
Mean (SD) 
Number 
analysed 
Age  
56.6 (11.9) 40 
 
58.6 (11.1) 8 
Pain duration (months) 63 (115) 39 31 (39) 8 
 
 
n (%)  n (%)  
Gender 
 
Females 
 
 
25 (63) 
 
40 
 
7 (88) 8 
Occupation 
 
Unemployed/retir
ed 
 
10 (48) 
 21  
4 (67) 
0 (0) 
2 (33) 
7 
Desk worker 4 (19)   
Manual worker 7 (33)   
 
Diagnosis 
 
Impingement 
 
3 (8) 
40  
1 (13) 
8 
 
Adhesive 
capsulitis 
5 (13)  0 (0)  
 Cuff dysfunction 3 (8)  1 (13)  
 AC OA 0 (0)  1 (13)  
 GH OA 1 (3)  0 (0)  
 Multiple 28 (68)  5 (61)  
Previous 
Treatment 
 None 
0 (0) 32 0 (0) 7 
 PT 2 (6)  1 (14)  
 Injection 2 (6)  0 (0)  
 Injection & PT 24(75)  4 (57)  
 
Injection, PT& 
surgery 
4 (13)  2 (29)  
Dominant 
arm 
 
Right 
 
32 (84)  38 
 
6 (75)  8 
Shoulder 
involved 
    
Right 
 
20 (51) 40 
 
4 (50) 8 
Key:   AC= acromioclavicular; GH= glenohumeral; EQED-5L= Eurqol 5 dimension scale; Max
m 
=maximum value; Min
m 
=minimum value; n= number of participants; NRS= numerical rating scale; 
OA= Osteoarthritis; PSFS= Patient specific functional score; SD= standard deviation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Summary statistics for outcomes across time points 
 
 
Key: BL= Baseline; EQED-5L= Eurqol 5 dimension scale; Max
m 
=maximum value; Min
m 
=minimum 
value; n= number of participants; NRS= numerical rating scale; PSFS= Patient specific functional 
score; SD= standard deviation; SD=standard deviation; SSNB= suprascapular nerve block. 
 
 
 
 
 
 
 
 
 
 
 
 Baseline 
(mean, SD) 
6 weeks 
(mean, SD) 
6 months 
(mean, SD) 
Pain intensity 
(0-10 NRS) 
 Number 
analysed 
 Number 
analysed 
 Number 
analysed 
PT palpation 
guided SSNB 
7.7 (1.1) 40 5.5 (2.5) 37 5.7 (2.9) 36 
Anaesthetist 
US-guided 
SSNB 
7.8 (1.4) 8 6.5 (8.0) 8 5.3 (3.5) 6 
       
Function 
(PSPF, range) 
      
PT palpation 
guided SSNB 
3.6 (2.0) 39 4.9 (2.4) 34   
Anaesthetist 
US-guided 
SSNB 
2.9 (1.7) 8 4.3 (3.1) 8   
       
Quality of life 
(EQ5D-5L) 
      
PT palpation 
guided SSNB 
0.461(0.220) 40 0.495 
(0.226) 
35   
Anaesthetist 
US-guided 
SSNB 
0.379 
(0.323) 
8 0.457 
(0.273) 
8   
  
 
 
 
 
 
 
 
 
 
Figure 1: SSNB using landmark guided method 
 
 
 
 
 
 
  
  
 
Figure 2: Mean point scores with 95% Confidence interval (CI) for pain (NRS) at baseline,  
               6 week and 6 month follow-up 
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